Celldex Therapeutics
CLDX
#4638
Rank
โ‚ฌ1.80 B
Marketcap
27,07ย โ‚ฌ
Share price
-0.06%
Change (1 day)
87.83%
Change (1 year)

Celldex Therapeutics (CLDX) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚ฌ48.19 Million

According to Celldex Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ48.19 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celldex Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚ฌ47.51 M9.07%
2024-12-31โ‚ฌ43.56 M32.1%
2023-12-31โ‚ฌ32.97 M33.33%
2022-12-31โ‚ฌ24.73 M11.25%
2021-12-31โ‚ฌ22.23 M3.26%
2020-12-31โ‚ฌ21.52 M-16.57%
2019-12-31โ‚ฌ25.8 M-7.02%
2018-12-31โ‚ฌ27.75 M-57.98%
2017-12-31โ‚ฌ66.05 M-41.08%
2016-12-31โ‚ฌ0.11 B158.19%
2015-12-31โ‚ฌ43.42 M45.27%
2014-12-31โ‚ฌ29.89 M51.21%
2013-12-31โ‚ฌ19.76 M-12.16%
2012-12-31โ‚ฌ22.5 M-0.16%
2011-12-31โ‚ฌ22.54 M-13.57%
2010-12-31โ‚ฌ26.07 M-43.9%
2009-12-31โ‚ฌ46.48 M25.79%
2008-12-31โ‚ฌ36.95 M413.54%
2007-12-31โ‚ฌ7.19 M-83.99%
2006-12-31โ‚ฌ44.95 M242.19%
2005-12-31โ‚ฌ13.13 M140.96%
2004-12-31โ‚ฌ5.45 M102.76%
2003-12-31โ‚ฌ2.68 M-27.72%
2002-12-31โ‚ฌ3.72 M-60.01%
2001-12-31โ‚ฌ9.3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
โ‚ฌ104.80 B 217,365.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ70.73 B 146,677.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ52.51 B 108,862.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
โ‚ฌ0.22 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚ฌ0.93 B 1,841.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.44 B 822.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.75 B 1,473.87%๐Ÿ‡บ๐Ÿ‡ธ USA